— Murray Aitken, IMS Health senior VP and executive director of the IMS Institute for Healthcare Informatics, during a recent conference call to discuss his institute's new report, Global Oncology Trend Report: A Review of 2015 and Outlook to 2020.
At Medicare is Simple, we look to educate and enable you to choose among Medicare plans to help find the policy that may best fit your needs. Get free quotes using our advanced quoting technology. HealthCare Reform is also a hot topic of interest to people of all ages, and we look to keep you updated on the issues relevant to learning more. Medicare Is Simple 800-442-4915
Wednesday, July 6, 2016
"This growth [of 11.5% from 2014 to 2015 in the cost of cancer drugs and supportive therapies] ...
... was very
much fueled by a sustained level of innovation. There are now 20 tumor types
treated by one or more of 70 therapies that have launched in the last five years....
Everyone is wrestling with this surge of innovation, [which IMS] expects to
continue at least through 2020."
— Murray Aitken, IMS Health senior VP and executive director of the IMS Institute for Healthcare Informatics, during a recent conference call to discuss his institute's new report, Global Oncology Trend Report: A Review of 2015 and Outlook to 2020.
— Murray Aitken, IMS Health senior VP and executive director of the IMS Institute for Healthcare Informatics, during a recent conference call to discuss his institute's new report, Global Oncology Trend Report: A Review of 2015 and Outlook to 2020.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment